AGC Biologics is attending the J.P. Morgan Biotech Showcase 2024
Meeting Location: Hilton Union Square in San Francisco
January 13 - 15
From pre-clinical to commercial, we are your friendly CDMO expert providing development and manufacturing services for protein-based biologics and advanced therapies. Set up a meeting with our team to discuss how we can help push your product to the next phase.
Our Leaders at the Show
Alberto Santagostino
Chief Executive Officer
Christoph Winterhalter
Chief Business Officer
Grace Kim
Sr. VP of Business Development - North America
Ben Clauberg
VP of Business Development - Europe
CDMO Manufacturing Capabilities
Mammalian
We have a proven track record of developing mammalian cell lines and processes from pre-clinical through commercial production.
Microbial
We have successfully expressed antibody fragments, growth factors, antigens, enzymes, and other proteins using multiple modes of expression.
MicrobialCell Therapy
Our global cell therapy services are backed by 30 years of scientific expertise, and the latest systems and technology.
Cell TherapyViral Vectors
We are building innovative and proprietary AAV, LVV, and RVV systems that meet the latest industry needs that can support any product platform.
Viral VectorsPlasmid DNA
Our non-GMP or GMP supply of material supports vaccine creation, RNA drugs, gene therapy and viral vector starting materials, and more.
Plasmid DNAMessenger RNA
We offer supplies in different qualities, and development scales and have extensive in-house analytical methods for today's latest applications.
Messenger RNAOur Global Network
Coming soon!